
Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) – Stock analysts at Maxim Group dropped their FY2026 earnings per share estimates for Oxbridge Re in a research report issued on Tuesday, November 10th. Maxim Group analyst A. Klee now anticipates that the insurance provider will post earnings per share of ($0.10) for the year, down from their previous forecast of ($0.04). The consensus estimate for Oxbridge Re’s current full-year earnings is ($0.04) per share. Maxim Group also issued estimates for Oxbridge Re’s Q4 2026 earnings at ($0.07) EPS, Q1 2027 earnings at ($0.10) EPS, Q3 2027 earnings at ($0.10) EPS, Q4 2027 earnings at ($0.10) EPS and FY2027 earnings at ($0.30) EPS.
OXBR has been the subject of several other reports. Zacks Research upgraded Oxbridge Re from a “strong sell” rating to a “hold” rating in a research note on Friday, October 16th. Weiss Ratings raised Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a research note on Friday, August 14th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $3.00.
Check Out Our Latest Report on OXBR
Oxbridge Re Stock Down 3.2%
NASDAQ OXBR opened at $0.91 on Thursday. Oxbridge Re has a 1-year low of $0.65 and a 1-year high of $1.86. The stock’s 50 day moving average is $1.12 and its two-hundred day moving average is $1.10.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The insurance provider reported ($0.05) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.05). Oxbridge Re had a negative net margin of 4.29% and a negative return on equity of 1.63%. The firm had revenue of $0.26 million for the quarter, compared to analyst estimates of $0.40 million.
Institutional Inflows and Outflows
A hedge fund recently bought a new position in Oxbridge Re stock. Citadel Advisors LLC bought a new position in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 65,855 shares of the insurance provider’s stock, valued at approximately $68,000. Citadel Advisors LLC owned about 0.81% of Oxbridge Re at the end of the most recent quarter. Hedge funds and other institutional investors own 5.64% of the company’s stock.
About Oxbridge Re
Oxbridge Re Holdings Limited is a specialty reinsurance holding company listed on the Nasdaq Capital Market under the symbol OXBR. The company conducts its reinsurance activities primarily through Oxbridge Reinsurance Limited, a Bermuda-based subsidiary, and focuses on providing collateralized property catastrophe reinsurance. Its coverage is designed to protect insurance companies against losses from major natural-catastrophe events, including hurricanes and other severe weather-related disasters.
Read More
- Five stocks we like better than Oxbridge Re
- Palantir’s Real Washington Risk Isn’t the Budget—It’s Oversight
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
